Thus, Taylor et al. analyzed miRNA profiles in EpCAM+ exosomes and found increased levels of miR-141, miR-200a, miR-200c, miR-200b, miR-203 and miR-205 in serum from patients with serous papillary adenocarcinoma compared to patients with benign tumors and healthy individuals [70]. The gene discussed is EPCAM; the disease is papillary serous cystadenocarcinoma.